Shift Bioscience has established a new team and facilities in Toronto to advance the development of its AI-powered virtual cell technology, aiming to fight age-related diseases. The new North American presence will enhance the company's capabilities and intellectual property portfolio in the AI field.
Company Information
Company
Shift Bioscience
Location
Cambridge, England, United Kingdom
About
Shift Bioscience is a Cambridge-based startup founded in 2017 that is exploring how generative AI models can be utilized to reverse the ageing process by rejuvenating cells. The company aims to address age-related illnesses through cellular reprogramming and has developed an AI cell simulation platform. Their technology seeks to predict gene sets that safely rejuvenate specific cells, tackling conditions like cardiovascular disease and osteoarthritis. Shift Bioscience represents an innovative approach in the biotech sector focused on cell simulation for target discovery.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Shift Bioscience ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.